发明名称 |
Pre-selection of subjects for therapeutic treatment with an Hsp90 inhibitor based on hypoxic status |
摘要 |
The present invention provides methods for the pre-selection of a subject for therapeutic treatment with an Hsp90 inhibitor based on modulated levels of hypoxia in cancerous cells in the subject. In one embodiment, the invention provides methods for the pre-selection of a subject for therapeutic treatment with an Hsp90 inhibitor based on modulated levels of lactate dehydrogenase (LDH) in a cell, e.g., a cancerous cell. The invention also provides methods for treating cancer in a subject by administering an effective amount of an Hsp90 inhibitor to the subject, wherein the subject has been selected based on a modulated level of hypoxia. The invention further provides kits to practice the methods of the invention. |
申请公布号 |
AU2013262914(A1) |
申请公布日期 |
2014.11.06 |
申请号 |
AU20130262914 |
申请日期 |
2013.05.15 |
申请人 |
SYNTA PHARMACEUTICALS CORP. |
发明人 |
VUKOVIC, VOJO;YALCIN, ILKER |
分类号 |
A61P35/00;A61K31/41;A61K31/4196 |
主分类号 |
A61P35/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|